Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News LIPAC Oncology takes NMIBC treatment TBC-1002 into phase 2 A trial Investigational NMIBC treatment TBC-1002 : LIPAC Oncology said that it has wrapped up a phase 1 clinical trial… bypharmanewsdailyOctober 27, 2019
